Vanguard Group Inc made a significant addition to its portfolio by acquiring 9,018,094 shares of Edwards Lifesciences Corp ...

IntroductionThe prosthetic heart valves market has witnessed significant transformation over the past few decades, driven by ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $81.0, with a high ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural ...

Edwards Lifesciences Corporation (EW), headquartered ... the company offers products such as tissue replacement heart valves, heart valve repair, hemodynamic monitoring devices, angioscopy ...

Edwards Lifesciences Corp. engages in the patient ... Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter ...

Edward Lifesciences' Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.

The Galien Foundation recently announced the nominees for its "Best Medical Technology" Pix Galien USA awards.

Katie Szyman, who led Edwards Lifesciences Corp.’s Critical Care unit that was recently sold for $4.2 billion, says ...

It has been a blockbuster year for women's health as the federal government and medtech place special focus on the wellbeing ...

The third quarter earnings season for MedTech stocks comes at a crucial time, following a tumultuous second quarter that forced investors to recalibrate expectations.  As per analysts at Citi Research ...